Global Griseofulvin Market Research Report 2023

Publication ID:

PB502235751

Publication Date:

February 16, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Highlights
The global Griseofulvin market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Griseofulvin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Griseofulvin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Griseofulvin include GlaxoSmithKline, Inga Pharmaceuticals, Dr. Reddy's Laboratories, CFL Pharmaceuticals Limited, Comed Chemicals Limited, BAL Pharma Ltd., Chifeng Pharmaceutical Co. Ltd and Nippon Kayaku, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Griseofulvin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Griseofulvin.
The Griseofulvin market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Griseofulvin market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Griseofulvin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GlaxoSmithKline
Inga Pharmaceuticals
Dr. Reddy's Laboratories
CFL Pharmaceuticals Limited
Comed Chemicals Limited
BAL Pharma Ltd.
Chifeng Pharmaceutical Co. Ltd
Nippon Kayaku
Segment by Type
Penicillium Nigrum
Penicillium Urticae
Other
Segment by Application
Agriculture
Medicine
Chemical Industry
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Griseofulvin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Griseofulvin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Griseofulvin Market Overview
1.1 Product Overview and Scope of Griseofulvin
1.2 Griseofulvin Segment by Type
1.2.1 Global Griseofulvin Market Value Comparison by Type (2023-2029)
1.2.2 Penicillium Nigrum
1.2.3 Penicillium Urticae
1.2.4 Other
1.3 Griseofulvin Segment by Application
1.3.1 Global Griseofulvin Market Value by Application: (2023-2029)
1.3.2 Agriculture
1.3.3 Medicine
1.3.4 Chemical Industry
1.3.5 Other
1.4 Global Griseofulvin Market Size Estimates and Forecasts
1.4.1 Global Griseofulvin Revenue 2018-2029
1.4.2 Global Griseofulvin Sales 2018-2029
1.4.3 Global Griseofulvin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Griseofulvin Market Competition by Manufacturers
2.1 Global Griseofulvin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Griseofulvin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Griseofulvin Average Price by Manufacturers (2018-2023)
2.4 Global Griseofulvin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Griseofulvin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Griseofulvin, Product Type & Application
2.7 Griseofulvin Market Competitive Situation and Trends
2.7.1 Griseofulvin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Griseofulvin Players Market Share by Revenue
2.7.3 Global Griseofulvin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Griseofulvin Retrospective Market Scenario by Region
3.1 Global Griseofulvin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Griseofulvin Global Griseofulvin Sales by Region: 2018-2029
3.2.1 Global Griseofulvin Sales by Region: 2018-2023
3.2.2 Global Griseofulvin Sales by Region: 2024-2029
3.3 Global Griseofulvin Global Griseofulvin Revenue by Region: 2018-2029
3.3.1 Global Griseofulvin Revenue by Region: 2018-2023
3.3.2 Global Griseofulvin Revenue by Region: 2024-2029
3.4 North America Griseofulvin Market Facts & Figures by Country
3.4.1 North America Griseofulvin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Griseofulvin Sales by Country (2018-2029)
3.4.3 North America Griseofulvin Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Griseofulvin Market Facts & Figures by Country
3.5.1 Europe Griseofulvin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Griseofulvin Sales by Country (2018-2029)
3.5.3 Europe Griseofulvin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Griseofulvin Market Facts & Figures by Country
3.6.1 Asia Pacific Griseofulvin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Griseofulvin Sales by Country (2018-2029)
3.6.3 Asia Pacific Griseofulvin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Griseofulvin Market Facts & Figures by Country
3.7.1 Latin America Griseofulvin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Griseofulvin Sales by Country (2018-2029)
3.7.3 Latin America Griseofulvin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Griseofulvin Market Facts & Figures by Country
3.8.1 Middle East and Africa Griseofulvin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Griseofulvin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Griseofulvin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Griseofulvin Sales by Type (2018-2029)
4.1.1 Global Griseofulvin Sales by Type (2018-2023)
4.1.2 Global Griseofulvin Sales by Type (2024-2029)
4.1.3 Global Griseofulvin Sales Market Share by Type (2018-2029)
4.2 Global Griseofulvin Revenue by Type (2018-2029)
4.2.1 Global Griseofulvin Revenue by Type (2018-2023)
4.2.2 Global Griseofulvin Revenue by Type (2024-2029)
4.2.3 Global Griseofulvin Revenue Market Share by Type (2018-2029)
4.3 Global Griseofulvin Price by Type (2018-2029)
5 Segment by Application
5.1 Global Griseofulvin Sales by Application (2018-2029)
5.1.1 Global Griseofulvin Sales by Application (2018-2023)
5.1.2 Global Griseofulvin Sales by Application (2024-2029)
5.1.3 Global Griseofulvin Sales Market Share by Application (2018-2029)
5.2 Global Griseofulvin Revenue by Application (2018-2029)
5.2.1 Global Griseofulvin Revenue by Application (2018-2023)
5.2.2 Global Griseofulvin Revenue by Application (2024-2029)
5.2.3 Global Griseofulvin Revenue Market Share by Application (2018-2029)
5.3 Global Griseofulvin Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Griseofulvin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GlaxoSmithKline Griseofulvin Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Inga Pharmaceuticals
6.2.1 Inga Pharmaceuticals Corporation Information
6.2.2 Inga Pharmaceuticals Description and Business Overview
6.2.3 Inga Pharmaceuticals Griseofulvin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Inga Pharmaceuticals Griseofulvin Product Portfolio
6.2.5 Inga Pharmaceuticals Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Griseofulvin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Dr. Reddy's Laboratories Griseofulvin Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 CFL Pharmaceuticals Limited
6.4.1 CFL Pharmaceuticals Limited Corporation Information
6.4.2 CFL Pharmaceuticals Limited Description and Business Overview
6.4.3 CFL Pharmaceuticals Limited Griseofulvin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CFL Pharmaceuticals Limited Griseofulvin Product Portfolio
6.4.5 CFL Pharmaceuticals Limited Recent Developments/Updates
6.5 Comed Chemicals Limited
6.5.1 Comed Chemicals Limited Corporation Information
6.5.2 Comed Chemicals Limited Description and Business Overview
6.5.3 Comed Chemicals Limited Griseofulvin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Comed Chemicals Limited Griseofulvin Product Portfolio
6.5.5 Comed Chemicals Limited Recent Developments/Updates
6.6 BAL Pharma Ltd.
6.6.1 BAL Pharma Ltd. Corporation Information
6.6.2 BAL Pharma Ltd. Description and Business Overview
6.6.3 BAL Pharma Ltd. Griseofulvin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BAL Pharma Ltd. Griseofulvin Product Portfolio
6.6.5 BAL Pharma Ltd. Recent Developments/Updates
6.7 Chifeng Pharmaceutical Co. Ltd
6.6.1 Chifeng Pharmaceutical Co. Ltd Corporation Information
6.6.2 Chifeng Pharmaceutical Co. Ltd Description and Business Overview
6.6.3 Chifeng Pharmaceutical Co. Ltd Griseofulvin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Chifeng Pharmaceutical Co. Ltd Griseofulvin Product Portfolio
6.7.5 Chifeng Pharmaceutical Co. Ltd Recent Developments/Updates
6.8 Nippon Kayaku
6.8.1 Nippon Kayaku Corporation Information
6.8.2 Nippon Kayaku Description and Business Overview
6.8.3 Nippon Kayaku Griseofulvin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Nippon Kayaku Griseofulvin Product Portfolio
6.8.5 Nippon Kayaku Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Griseofulvin Industry Chain Analysis
7.2 Griseofulvin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Griseofulvin Production Mode & Process
7.4 Griseofulvin Sales and Marketing
7.4.1 Griseofulvin Sales Channels
7.4.2 Griseofulvin Distributors
7.5 Griseofulvin Customers
8 Griseofulvin Market Dynamics
8.1 Griseofulvin Industry Trends
8.2 Griseofulvin Market Drivers
8.3 Griseofulvin Market Challenges
8.4 Griseofulvin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

GlaxoSmithKline
Inga Pharmaceuticals
Dr. Reddy's Laboratories
CFL Pharmaceuticals Limited
Comed Chemicals Limited
BAL Pharma Ltd.
Chifeng Pharmaceutical Co. Ltd
Nippon Kayaku

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂